help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gregory, T. J.
Right arrow Articles by Gold, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gregory, T. J.
Right arrow Articles by Gold, A. J.

Am. J. Respir. Crit. Care Med., Vol 155, No. 4, Apr 1997, 1309-1315.

Bovine surfactant therapy for patients with acute respiratory distress syndrome

TJ Gregory, KP Steinberg, R Spragg, JE Gadek, TM Hyers, WJ Longmore, MA Moxley, GZ Cai, RD Hite, RM Smith, LD Hudson, C Crim, P Newton, BR Mitchell and AJ Gold
Department of Internal Medicine, Ohio State University Hospital, Columbus, USA.

Lung surfactant is deficient in patients with acute respiratory distress syndrome (ARDS). We performed a randomized, prospective, controlled, open-label clinical study of administration of a bovine surfactant to patients with ARDS to obtain preliminary information about its safety and efficacy. Patients received either surfactant by endotracheal instillation in addition to standard therapy or standard therapy only. Three different groups of patients receiving surfactant were studied: patients receiving up to eight doses of 50 mg phospholipids/kg, those receiving up to eight doses of 100 mg phospholipids/kg, and those receiving up to four doses of 100 mg phospholipids/kg. Outcome measures included ventilatory support parameters, arterial blood gases, organ system failures, bronchoalveolar lavage (BAL) analyses, immunologic analyses, survival, and adverse events during the 28-d study period. Fifty-nine study patients were evaluable; 43 in the surfactant group and 16 in the control group. The FI(O2) at 120 h after treatment began was significantly decreased only for patients who received up to four doses of 100 mg phospholipids/kg surfactant as compared with control patients (p = 0.011). Mortality in the same group of patients was 18.8%, as compared with 43.8% in the control group (p = 0.075). The surfactant instillation was generally well tolerated, and no safety concerns were identified. This pilot study presents preliminary evidence that surfactant might have therapeutic benefit for patients with ARDS, and provides rationale for further clinical study of this agent.


This article has been cited by other articles:


Home page
J Intensive Care MedHome page
K. M. Schuster, R. Alouidor, and E. S. Barquist
Nonventilatory Interventions in the Acute Respiratory Distress Syndrome
J Intensive Care Med, January 1, 2008; 23(1): 19 - 32.
[Abstract] [PDF]


Home page
ChestHome page
M. Ikegami, E. A. Scoville, S. Grant, T. Korfhagen, W. Brondyk, R. K. Scheule, and J. A. Whitsett
Surfactant Protein-D and Surfactant Inhibit Endotoxin-Induced Pulmonary Inflammation
Chest, November 1, 2007; 132(5): 1447 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
A. Braun, P. C. Stenger, H. E. Warriner, J. A. Zasadzinski, K. W. Lu, and H. W. Taeusch
A Freeze-Fracture Transmission Electron Microscopy and Small Angle X-Ray Diffraction Study of the Effects of Albumin, Serum, and Polymers on Clinical Lung Surfactant Microstructure
Biophys. J., July 1, 2007; 93(1): 123 - 139.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P. Markart, C. Ruppert, M. Wygrecka, T. Colaris, B. Dahal, D. Walmrath, H. Harbach, J. Wilhelm, W. Seeger, R. Schmidt, et al.
Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids
Thorax, July 1, 2007; 62(7): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Struber, S. Fischer, J. Niedermeyer, G. Warnecke, B. Gohrbandt, A. Gorler, A. R. Simon, A. Haverich, and J. M. Hohlfeld
Effects of exogenous surfactant instillation in clinical lung transplantation: A prospective, randomized trial
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1620 - 1625.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. P. Stevens and R. A. Sinkin
Surfactant Replacement Therapy
Chest, May 1, 2007; 131(5): 1577 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
P. C. Stenger and J. A. Zasadzinski
Enhanced Surfactant Adsorption via Polymer Depletion Forces: A Simple Model for Reversing Surfactant Inhibition in Acute Respiratory Distress Syndrome
Biophys. J., January 1, 2007; 92(1): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
M. Cepkova and M. A. Matthay
Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
J Intensive Care Med, May 1, 2006; 21(3): 119 - 143.
[Abstract] [PDF]


Home page
Eur Respir JHome page
W. Huang, L. A. McCaig, R. A. W. Veldhuizen, L-J. Yao, and J. F. Lewis
Mechanisms responsible for surfactant changes in sepsis-induced lung injury
Eur. Respir. J., December 1, 2005; 26(6): 1074 - 1079.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. W. Taeusch, J. B. de la Serna, J. Perez-Gil, C. Alonso, and J. A. Zasadzinski
Inactivation of Pulmonary Surfactant Due to Serum-Inhibited Adsorption and Reversal by Hydrophilic Polymers: Experimental
Biophys. J., September 1, 2005; 89(3): 1769 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
B. S. Burleson and E. D. Maki
Acute Respiratory Distress Syndrome
Journal of Pharmacy Practice, April 1, 2005; 18(2): 118 - 131.
[Abstract] [PDF]


Home page
JAMAHome page
D. F. Willson, N. J. Thomas, B. P. Markovitz, L. A. Bauman, J. V. DiCarlo, S. Pon, B. R. Jacobs, L. S. Jefferson, M. R. Conaway, E. A. Egan, et al.
Effect of Exogenous Surfactant (Calfactant) in Pediatric Acute Lung Injury: A Randomized Controlled Trial
JAMA, January 26, 2005; 293(4): 470 - 476.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. G. Spragg, J. F. Lewis, H.-D. Walmrath, J. Johannigman, G. Bellingan, P.-F. Laterre, M. C. Witte, G. A. Richards, G. Rippin, F. Rathgeb, et al.
Effect of Recombinant Surfactant Protein C-Based Surfactant on the Acute Respiratory Distress Syndrome
N. Engl. J. Med., August 26, 2004; 351(9): 884 - 892.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
P. Prodhan and N. Noviski
Pediatric Acute Hypoxemic Respiratory Failure: Management of Oxygenation
J Intensive Care Med, May 1, 2004; 19(3): 140 - 153.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Friedrich, J. Borgermann, F. H. Splittgerber, M. Brinkmann, J. C. Reidemeister, R. E. Silber, W. Seeger, R. Schmidt, and A. Gunther
Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 335 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Gunther, M. Balser, R. Schmidt, P. Markart, A. Olk, J. Borgermann, F. H. Splittgerber, W. Seeger, and I. Friedrich
Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 344 - 354.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. Raychaudhuri, S. Abraham, T. L. Bonfield, A. Malur, A. Deb, J. A. DiDonato, M. S. Kavuru, and M. J. Thomassen
Surfactant Blocks Lipopolysaccharide Signaling by Inhibiting both Mitogen-Activated Protein and I{kappa}B Kinases in Human Alveolar Macrophages
Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 228 - 232.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y.-Z. Wu, S. Medjane, S. Chabot, F. S. Kubrusly, I. Raw, M. Chignard, and L. Touqui
Surfactant Protein-A and Phosphatidylglycerol Suppress Type IIA Phospholipase A2 Synthesis via Nuclear Factor-{kappa}B
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 692 - 699.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. G. Spragg, J. F. Lewis, W. Wurst, D. Hafner, R. P. Baughman, M. D. Wewers, and J. J. Marsh
Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant
Am. J. Respir. Crit. Care Med., June 1, 2003; 167(11): 1562 - 1566.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J Cranshaw, M J D Griffiths, and T W Evans
The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS
Thorax, September 1, 2002; 57(9): 823 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. V. Diemel, M. M. E. Snel, A. J. Waring, F. J. Walther, L. M. G. van Golde, G. Putz, H. P. Haagsman, and J. J. Batenburg
Multilayer Formation upon Compression of Surfactant Monolayers Depends on Protein Concentration as Well as Lipid Composition. AN ATOMIC FORCE MICROSCOPY STUDY
J. Biol. Chem., June 7, 2002; 277(24): 21179 - 21188.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Anzueto
Exogenous surfactant in acute respiratory distress syndrome: more is better
Eur. Respir. J., May 1, 2002; 19(5): 787 - 789.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Gunther, R. Schmidt, J. Harodt, T. Schmehl, D. Walmrath, C. Ruppert, F. Grimminger, and W. Seeger
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties
Eur. Respir. J., May 1, 2002; 19(5): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Walmrath, F. Grimminger, D. Pappert, C. Knothe, U. Obertacke, A. Benzing, A. Gunther, T. Schmehl, H. Leuchte, and W. Seeger
Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics
Eur. Respir. J., May 1, 2002; 19(5): 805 - 810.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Kesecioglu, M.J. Schultz, J.J. Haitsma, G.J. den Heeten, and B. Lachmann
Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome
Eur. Respir. J., May 1, 2002; 19(5): 820 - 826.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. CAMPBELL, K. BOSMA, A. BRACKENBURY, L. MCCAIG, L.-J. YAO, R. VELDHUIZEN, and J. LEWIS
Polyethylene Glycol (PEG) Attenuates Exogenous Surfactant in Lung-injured Adult Rabbits
Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 475 - 480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. W. LU, H. W. TAEUSCH, B. ROBERTSON, J. GOERKE, and J. A. CLEMENTS
Polyethylene Glycol/Surfactant Mixtures Improve Lung Function after HCl and Endotoxin Lung Injuries
Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1531 - 1536.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. Wolf, H. Lohbrunner, T. Busch, A. Sterner-Kock, M. Deja, A. Sarrafzadeh, U. Neumann, and U. Kaisers
Small dose of exogenous surfactant combined with partial liquid ventilation in experimental acute lung injury: effects on gas exchange, haemodynamics, lung mechanics, and lung pathology
Br. J. Anaesth., October 1, 2001; 87(4): 593 - 601.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
K. Tashiro, K. Yamada, T. Konzaki, K. Yamamoto, S. Ohmura, T. Kobayashi, and Y. Suzuki
Aerosolized surfactant therapy for endotoxin-induced experimental acute respiratory distress syndrome in rats
Br. J. Anaesth., August 1, 2001; 87(2): 266 - 271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
E. P. Ingenito, R. Mora, M. Cullivan, Y. Marzan, K. Haley, L. Mark, and L. A. Sonna
Decreased Surfactant Protein-B Expression and Surfactant Dysfunction in a Murine Model of Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. BRACKENBURY, P. S. PULIGANDLA, L. A. McCAIG, V. NIKORE, L.-J. YAO, R. A. W. VELDHUIZEN, and J. F. LEWIS
Evaluation of Exogenous Surfactant in HCl-induced Lung Injury
Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1135 - 1142.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. W. Kramer, A. H. Jobe, and M. Ikegami
Exogenous surfactant changes the phenotype of alveolar macrophages in mice
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L689 - L694.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. T. Schermuly, A. Gunther, M. Ermert, L. Ermert, H. A. Ghofrani, N. Weissmann, F. Grimminger, W. Seeger, and D. Walmrath
Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L792 - L800.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. L. PILON
Rationale for the Development of Recombinant Human CC10 as a Therapeutic for Inflammatory and Fibrotic Disease
Ann. N.Y. Acad. Sci., December 1, 2000; 923(1): 280 - 299.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
A. Hartog, D. Gommers, J. J. Haitsma, and B. Lachmann
Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure
Br. J. Anaesth., November 1, 2000; 85(5): 752 - 756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. W. Kramer, M. Ikegami, and A. H. Jobe
Surfactant phospholipid catabolic rate is pool size dependent in mice
Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L842 - L848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. W. LU, H. WILLIAM TAEUSCH, B. ROBERTSON, J. GOERKE, and J. A. CLEMENTS
Polymer-Surfactant Treatment of Meconium-induced Acute Lung Injury
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Mora, S. Arold, Y. Marzan, B. Suki, and E. P. Ingenito
Determinants of surfactant function in acute lung injury and early recovery
Am J Physiol Lung Cell Mol Physiol, August 1, 2000; 279(2): L342 - L349.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. S. Puligandla, T. Gill, L. A. McCaig, L.-J. Yao, R. A. W. Veldhuizen, F. Possmayer, and J. F. Lewis
Alveolar environment influences the metabolic and biophysical properties of exogenous surfactants
J Appl Physiol, March 1, 2000; 88(3): 1061 - 1071.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. G. Spragg, R. M. Smith, K. Harris, J. Lewis, D. Hafner, and P. Germann
Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury
J Appl Physiol, February 1, 2000; 88(2): 674 - 681.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. G. Janz, R. Madan, J. J. Marini, W. R. Summer, G. U. Meduri, R. M. Smith, G. R. Epler, and J. Schnader
Clinical Conference on Management Dilemmas: Progressive Infiltrates and Respiratory Failure
Chest, February 1, 2000; 117(2): 562 - 572.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Z.-H. ZHOU, B. SUN, K. LIN, and L.-W. ZHU
Prevention of Rabbit Acute Lung Injury by Surfactant, Inhaled Nitric Oxide, and Pressure Support Ventilation
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 581 - 588.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. G. Spragg and J. Li
Effect of Phosphocholine Cytidylyltransferase Overexpression on Phosphatidylcholine Synthesis in Alveolar Type II Cells and Related Cell Lines
Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 116 - 124.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. T. SCHERMULY, A. GÜNTHER, N. WEISSMANN, H. A. GHOFRANI, W. SEEGER, F. GRIMMINGER, and D. WALMRATH
Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (VA/Q) Mismatch in a Model of Acute Lung Injury
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 152 - 159.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. E. WISWELL, R. M. SMITH, L. B. KATZ, L. MASTROIANNI, D. Y. WONG, D. WILLMS, S. HEARD, M. WILSON, R. D. HITE, A. ANZUETO, et al.
Bronchopulmonary Segmental Lavage with Surfaxin (KL4-Surfactant) for Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1188 - 1195.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
B. M. Elhalwagi, M. Zhang, M. Ikegami, H. S. Iwamoto, R. E. Morris, M. L. Miller, K. Dienger, and F. X. McCormack
Normal Surfactant Pool Sizes and Inhibition-Resistant Surfactant from Mice That Overexpress Surfactant Protein A
Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 380 - 387.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Griese, C. Wilnhammer, S. Jansen, and C. Rinker
CARDIOPULMONARY BYPASS REDUCES PULMONARY SURFACTANT ACTIVITY IN INFANTS
J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. LEWIS, L. MCCAIG, D. HÄFNER, R. SPRAGG, R. VELDHUIZEN, and C. KERR
Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 741 - 747.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. SUWABE, K. OTAKE, N. YAKUWA, H. SUZUKI, M. ITO, H. TOMOIKE, Y. SAITO, and K. TAKAHASHI
Artificial Surfactant (Surfactant TA) Modulates Adherence and Superoxide Production of Neutrophils
Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1890 - 1899.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. LUTZ, D. CARNEY, C. FINCK, A. PICONE, L. A. GATTO, A. PASKANIK, E. LANGENBACK, and G. NIEMAN
Aerosolized Surfactant Improves Pulmonary Function in Endotoxin-induced Lung Injury
Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 840 - 845.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. L. Kerr, Y. Ito, S. E. E. Manwell, R. A. W. Veldhuizen, L.-J. Yao, L. A. McCaig, and J. F. Lewis
Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant
J Appl Physiol, August 1, 1998; 85(2): 676 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. F. ZHU, B. SUN, S. F. NIU, Y. Y. CAI, K. LIN, R. LINDWALL, and B. ROBERTSON
Combined Surfactant Therapy and Inhaled Nitric Oxide in Rabbits with Oleic Acid-induced Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 437 - 443.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. BALARAMAN, J. MEISTER, T. L. KU, S. L. SOOD, E. TAM, J. KILLEEN, C. F. T. UYEHARA, E. EGAN, and D. EASA
Lavage Administration of Dilute Surfactants after Acute Lung Injury in Neonatal Piglets
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 12 - 17.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. HAFNER, P.-G. GERMANN, and D. HAUSCHKE
Effects of rSP-C Surfactant on Oxygenation and Histology in a Rat-Lung-Lavage Model of Acute Lung Injury
Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 270 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. J. MASON and R. G. CRYSTAL
Pulmonary Cell Biology
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S72 - S81.
[Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. F. Fok, M. Al-Essa, M. Dolovich, F. Rasid, and H. Kirpalani
Nebulisation of surfactants in an animal model of neonatal respiratory distress
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1998; 78(1): 3F - 9.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. ITO, S. E. E. MANWELL, C. L. KERR, R. A. W. VELDHUIZEN, L.-J. YAO, D. BJARNESON, L. A. MCCAIG, A. J. BARTLETT, and J. F. LEWIS
Effects of Ventilation Strategies on the Efficacy of Exogenous Surfactant Therapy in a Rabbit Model of Acute Lung Injury
Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 149 - 155.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. DREYFUSS and G. SAUMON
Ventilator-induced Lung Injury . Lessons from Experimental Studies
Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 294 - 323.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society